ArticleBioanalysis2025

Refined ADA testing strategy to overcome sRANKL interference in denosumab/FKS518 immunogenicity assessment.

Anna Lucia Buccarello et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.